SRTS
Sensus Healthcare Inc
2.90$
+1.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 84.1% | 88.9% | 88.5% | 95.0% | 95.9% | 92.1% | 89.9% | 96.9% | 93.8% | 92.2% | 91.3% | 86.5% | |
| – | 65.4% | 52.6% | 26.6% | 53.5% | 37.5% | 21.9% | 53.2% | 45.0% | 45.0% | 43.1% | 35.5% | 41.6% | |
| – | 65.4% | 52.6% | 60.7% | 59.4% | 46.2% | 41.9% | 53.2% | 45.0% | 45.0% | 43.1% | 35.5% | 41.6% | |
| – | 5.9% | 21.5% | 16.4% | 26.3% | 39.5% | 37.9% | 13.5% | 37.6% | 30.5% | 19.8% | 31.7% | 11.4% | |
| – | 12.2% | 10.4% | 6.6% | 6.2% | 4.9% | 8.1% | 15.8% | 5.5% | 6.2% | 22.1% | 16.2% | 27.5% | |
| – | 3.8% | 3.3% | 2.3% | 2.1% | 2.7% | 6.7% | 4.8% | 2.4% | 0.4% | – | – | – | |
| – | – | – | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| – | 11.8% | 7.5% | 3.3% | 2.8% | 1.3% | 0.9% | 1.2% | 0.5% | 0.1% | – | – | – | |
| – | 40.4% | 38.5% | 19.4% | 38.0% | 20.4% | 24.2% | 23.3% | 19.3% | 15.3% | 9.1% | 10.2% | 9.3% | |
| – | 39.7% | 38.1% | 19.3% | 37.6% | 18.1% | 17.5% | 17.3% | 18.5% | 13.6% | 7.8% | 9.5% | 8.9% | |
| – | 5.4% | 4.4% | -14.6% | 11.8% | -15.5% | 0.8% | 1.1% | 0.7% | 0.3% | 0.3% | 0.3% | 0.5% | |
| – | 15.6% | 23.9% | 14.6% | 21.6% | 15.5% | 12.9% | 10.3% | 12.6% | 9.7% | 5.2% | 7.7% | 6.3% | |
| – | – | – | 0.0% | 11.8% | – | – | 1.0% | – | – | – | – | – | |
| – | 59.6% | 61.5% | 80.6% | 62.0% | 79.6% | 75.8% | 76.7% | 80.7% | 84.7% | 90.9% | 89.8% | 90.7% | |
| – | -103.8% | -77.3% | -41.1% | -61.1% | -40.7% | -41.2% | -78.8% | -55.7% | 11.1% | 12.6% | 21.6% | 10.8% | |
| – | 142.4% | 111.9% | 63.5% | 70.3% | 42.5% | 44.0% | 58.7% | 51.2% | 29.3% | 30.3% | 26.3% | 30.8% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.